Classifying recurrent Mycobacterium tuberculosis cases in Georgia using MIRU-VNTR typing.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 06 06 2019
accepted: 24 09 2019
entrez: 19 10 2019
pubmed: 19 10 2019
medline: 17 3 2020
Statut: epublish

Résumé

Recurrent tuberculosis (TB) is one of the main challenges in TB control. Genotyping based on Mycobacterial Interspersed Repetitive Units-Variable Tandem Repeats (MIRU-VNTR) has been widely used to differentiate between relapse and reinfection, which are the two main causes of recurrent TB. There is a lack of data regarding the causes of TB recurrence in Georgia, and while differentiating between relapse and reinfection plays a key role in defining appropriate interventions, the required genotyping methodologies have not been implemented. The objective of this study was to implement MIRU-VNTR genotyping at the National Center for Tuberculosis and Lung Diseases (NCTBLD) and differentiate between relapse and reinfection in multidrug resistant (MDR-) TB patients from Tbilisi, Georgia. Recurrent MDR tuberculosis cases from 2014-2016 diagnosed at NCTLD were included in the study when bacterial samples from both episodes were available. Genotyping based on the MIRU-VNTR 24 loci was implemented and used for differentiating between relapse and reinfection. Paired samples showing the same MIRU-VNTR pattern or one locus difference were classified as relapse, while two and more loci differences were treated as reinfection. Exact logistic regression was used to identify predictors of recurrence. Thirty two MDR-TB patients (64 samples) were included and MIRU-VNTR 24 typing was performed on the corresponding paired samples. Of the 32 patients, 25 (83.3%) were identified as relapse while 5 (16.7%) were due to re-infection. Patients with a history of incarceration were significantly associated with TB reinfection (p< 0.05). Recurrent TB in MDR patients in Georgia are mainly caused by relapse, raising concerns on the efficacy of the TB control program. An association between incarceration and reinfection likely reflects high levels of ongoing TB transmission in prisons, indicating the need for better TB infection control measures in these settings. Our results add to the rationale for implementing genotypic surveillance of TB more broadly to support TB control in Georgia.

Identifiants

pubmed: 31626647
doi: 10.1371/journal.pone.0223610
pii: PONE-D-19-15714
pmc: PMC6799914
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0223610

Subventions

Organisme : FIC NIH HHS
ID : D43 TW007124
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

BMC Infect Dis. 2014 Oct 24;14:548
pubmed: 25338623
Am J Respir Crit Care Med. 2005 Jun 15;171(12):1430-5
pubmed: 15831840
BMC Infect Dis. 2018 Jun 7;18(1):265
pubmed: 29879906
Emerg Infect Dis. 2003 Dec;9(12):1633-5
pubmed: 14720411
PLoS One. 2019 Feb 15;14(2):e0211972
pubmed: 30768624
PLoS One. 2017 Mar 23;12(3):e0174373
pubmed: 28334036
J Infect Dis. 2007 Jul 15;196(2):281-8
pubmed: 17570116
Clin Microbiol Infect. 2016 Jun;22(6):549-54
pubmed: 27021423
Int J Mycobacteriol. 2018 Jan-Mar;7(1):1-6
pubmed: 29516879
Pathog Dis. 2017 Apr 1;75(3):
pubmed: 28334088
Int J Infect Dis. 2017 Mar;56:111-116
pubmed: 27794468
J Clin Microbiol. 2006 Dec;44(12):4498-510
pubmed: 17005759
BMC Public Health. 2012 Feb 13;12:124
pubmed: 22329930
BMC Res Notes. 2013 Dec 28;6:561
pubmed: 24373461
J R Soc Interface. 2009 Jan 6;6(30):11-5
pubmed: 18577502
Int J Infect Dis. 2018 Sep;74:31-37
pubmed: 29944930
Respir Res. 2006 Jul 17;7:99
pubmed: 16846493
PLoS One. 2017 May 4;12(5):e0176473
pubmed: 28472053
Nat Rev Microbiol. 2019 Sep;17(9):533-545
pubmed: 31209399
Int J Tuberc Lung Dis. 2017 May 1;21(5):550-555
pubmed: 28399970
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):717-20
pubmed: 11254530
Health Hum Rights. 2011 Dec 15;13(2):E73-81
pubmed: 22773034
PLoS One. 2013 Jun 11;8(6):e64898
pubmed: 23776440
Ann Am Thorac Soc. 2015 Nov;12(11):1619-26
pubmed: 26325356

Auteurs

Nino Maghradze (N)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
National Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.

Levan Jugheli (L)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
National Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.

Sonia Borrell (S)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Nestani Tukvadze (N)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
National Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.

Rusudan Aspindzelashvili (R)

National Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.

Zaza Avaliani (Z)

National Center for Tuberculosis and Lung Diseases (NCTLD), Tbilisi, Georgia.

Klaus Reither (K)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Sebastien Gagneux (S)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH